A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.
Statins are prescribed widely to lower plasma low-density lipoprotein (LDL) concentrations and cardiovascular disease risk and have been shown to have beneficial effects in a broad range of patients. However, statins are associated with an increased risk, albeit small, of clinical myopathy and type...
主要な著者: | Mangravite, L, Engelhardt, B, Medina, M, Smith, J, Brown, C, Chasman, D, Mecham, B, Howie, B, Shim, H, Naidoo, D, Feng, Q, Rieder, M, Chen, Y, Rotter, J, Ridker, P, Hopewell, J, Parish, S, Armitage, J, Collins, R, Wilke, R, Nickerson, D, Stephens, M, Krauss, R |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2013
|
類似資料
-
A statin-dependent QTL for GATM expression is associated with statin-induced myopathy
著者:: Mangravite, L, 等
出版事項: (2013) -
Myopathy associated with statin therapy.
著者:: Hilton-Jones, D
出版事項: (2008) -
Genome-wide association of statin-induced myopathy
著者:: Link, E
出版事項: (2009) -
SLCO1B1 variants and statin-induced myopathy--a genomewide study.
著者:: Link, E, 等
出版事項: (2008) -
PNA HyBeacons for analysis of human mutations related to statin-induced myopathy.
著者:: Gale, N, 等
出版事項: (2011)